| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244362C Pill for treating lung disease, and its preparing method |
| 03/08/2006 | CN1244332C 九节茶提取物和它的应用 Day Nine tea extract and its application |
| 03/08/2006 | CN1244330C Application of golden buckwheat rhizome in the preparing process of medicine for treating respiratory syncytial virus infected disease |
| 03/08/2006 | CN1244320C Nose spray agent |
| 03/07/2006 | US7009060 2-oxo-benzimidazolyl substituted ethanolamine derivatives and their use as β3 agonists |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008951 Such as asthma or chronic obstructive pulmonary disease; mixture of a corticoid such as budesonide, fluticasone propionate or mometasone furoate and 5-(1-hydroxy-2-((5,6-diethylindan-2-yl)amino)ethyl)8-hydroxy-1,2-dihydroquinolin-2-one or its salt |
| 03/07/2006 | US7008946 CCR5 antagonists useful for treating AIDS |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/02/2006 | WO2006023791A2 Methods and compositions for treating allergic inflammation |
| 03/02/2006 | WO2006023454A1 Crystalline form of a biphenyl compound |
| 03/02/2006 | WO2006023396A2 Vla-4 antagonists |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006021418A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | WO2005009989A8 Nicotinamide derivatives useful as pde4 inhibitors |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | US20060046999 Monocyclic aroylpyridinones as antiinflammatory agents |
| 03/02/2006 | US20060046995 anti-bacterial agents; staphylococci; coliform bacteria; 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; bridged bicyclic ureas or carbamates having bridgehead nitrogen |
| 03/02/2006 | DE102004041253A1 Neues Verfahren zur Herstellung von Tiotropiumsalzen New method for the preparation of tiotropium |
| 03/02/2006 | CA2577748A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | CA2577631A1 Methods and compositions for treating allergic inflammation |
| 03/02/2006 | CA2576562A1 Nutritional composition comprising galactose-containing indigestible oligosaccharides |
| 03/02/2006 | CA2575200A1 Biphenyloxyacetic acid derivatives for the treatment of respiratory disease |
| 03/01/2006 | EP1630230A2 Streptococcus pneumoniae proteins and nucleic acids |
| 03/01/2006 | EP1630165A1 [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1630160A1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents |
| 03/01/2006 | EP1629853A1 Method for preparing powder exhibiting low susceptibility to electrification |
| 03/01/2006 | EP1629850A1 Nutritional composition comprising indigestible oligosaccharides |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628682A2 Composition comprising a pde4 inhibitor and a pde5 inhibitor |
| 03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
| 03/01/2006 | EP1628634A1 Novel lipid mixtures for synthetic surfactants |
| 03/01/2006 | EP1446119B1 Compositions comprising ipatropium and xylometazoline for treatment of the common cold |
| 03/01/2006 | EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1333823A4 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1206471B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 03/01/2006 | EP1133285B1 A process for producing particles with a converted amorphous and/or meta-stable crystalline region into crystalline state |
| 03/01/2006 | EP1049488B1 Method of and compositions for immunization with the pseudomonas aeruginosa v-antigen |
| 03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
| 03/01/2006 | CN1741992A 大麻素受体配体 Cannabinoid receptor ligands |
| 03/01/2006 | CN1741990A Arylalkylcarbamate derivatives production and use thereof in therapy |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741819A Sustained release composition for oral administration of drugs |
| 03/01/2006 | CN1740151A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1740150A 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739779A Trachitis treating Chinese medicine prepn |
| 03/01/2006 | CN1739755A Intensified loquet distillate and its prepn |
| 03/01/2006 | CN1739748A Cold treating medicine and its prepn |
| 03/01/2006 | CN1739732A Compound Chuanhuning prepn and its prepn process |
| 03/01/2006 | CN1739704A Chinese medicine oral liquid specially for treating tonsillitis |
| 03/01/2006 | CN1739694A Medicine for treating acute and chronic bronchial asthma and cough and its prepn |
| 03/01/2006 | CN1739686A Chinese medicine injection for clearing away heat and toxic matter and its prepn process |
| 03/01/2006 | CN1739677A Houjiling prepn for treating throat diseases and its use |
| 03/01/2006 | CN1739667A Capsule for treating rhinitis and its prepn |
| 03/01/2006 | CN1739666A Capsule prepn for treating laryngopharyngitis and tonsillitis and its prepn process |
| 03/01/2006 | CN1739655A Quality control method of Qingkailing injection prepn |
| 03/01/2006 | CN1739652A Chinese medicine prepn with functions of clearing away heat and toxic matter and tranquilizing and its prepn process |
| 03/01/2006 | CN1739645A Infant Kechuanling Chinese medicine prepn for treating dyspneic cough and its prepn |
| 03/01/2006 | CN1739632A Antiphlogistic bezoar dripping pill and its prepn process |
| 03/01/2006 | CN1739611A Stasis relieving oral liquid for treating rhinitis and its prepn |
| 03/01/2006 | CN1739600A Chinese medicine prepn for treating respiratory tract diseases and its prepn process and quality control method |
| 03/01/2006 | CN1739596A Recipe and prepn of injection containing volatile honeysuckle oil |
| 03/01/2006 | CN1739540A Application of arctiin in preparing medicine for treating rhinitis and nasosinusitis |
| 03/01/2006 | CN1739529A Application of fritillarine and its derivatives in preparing medicine for relieving cough, eliminating phlegm and relieving asthma |
| 03/01/2006 | CN1739528A Application of monomeric alkaloid extracted from Hubei fritillary bulb in preparing medicine for relieving cough, eliminating phlegm and relieving asthma |
| 03/01/2006 | CN1739525A Nanometer partical administration system of prostaglandin E1 coated with polyglycol derived phospholipid |
| 03/01/2006 | CN1739516A Application of penehyclidine hydrochloride in preparing medicine |
| 03/01/2006 | CN1739514A Oral loratadine disintegrating tablet and its prepn |
| 03/01/2006 | CN1243772C Dauricine polysaccharide, its extraction method and the use of medicine with the compound as active component |
| 03/01/2006 | CN1243751C Piperidine compounds as anti-allergic medicine |
| 03/01/2006 | CN1243747C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme IKK-2 |
| 03/01/2006 | CN1243735C 2-lminopyrrolidine derivatives |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243563C Activating blood circulation and resolving sputum and relieving asthma medicine |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005449 Tolterodine salts |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/23/2006 | WO2006019169A1 3-epivitamin d3 derivative and therapeutic agent containing the same |
| 02/23/2006 | WO2006018708A2 Pyrrolidine derivatives as muscarinic receptor antagonists |
| 02/23/2006 | WO2005102319A3 Use of melatonin in preventing postoperative complications |
| 02/23/2006 | US20060040985 Therapeutic agent for treating respiratory diseases containing 4-hydroxypiperidine derivative as active ingredient |
| 02/23/2006 | US20060040984 Novel piperidine derivatives for use in the treatment of chemokine medicated disease states |
| 02/23/2006 | US20060040976 Thiobenzimidazole derivatives |
| 02/23/2006 | US20060040972 Pyrazolonaphthyridine derivative |